The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Recent advances in the construction of antibody–drug conjugates
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trastuzumab emtansine for HER2-positive advanced breast cancer
Verma, S., Miles, D., Gianni, L., Krop, I. E., Welslau, M., Baselga, J., Pegram, M., Oh, D.-Y., Diéras, V., Guardino, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1209124 · Cited by 3,834
Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
Junutula, J. R., Raab, H., Clark, S., Bhakta, S., Leipold, D. D., Weir, S., Chen, Y., Simpson, M., Tsai, S. P., Dennis, M. S., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt.1480 · Cited by 1,382
Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas
Younes, A., Bartlett, N. L., Leonard, J. P., Kennedy, D. A., Lynch, C. M., Sievers, E. L., & Forero-Torres, A. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002965 · Cited by 1,368
Effects of Drug Loading on the Antitumor Activity of a Monoclonal Antibody Drug Conjugate
Hamblett, K. J., Senter, P. D., Chace, D. F., Sun, M. M. C., Lenox, J., Cerveny, C. G., Kissler, K. M., Bernhardt, S. X., Kopcha, A. K., Zabinski, R. F., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0789 · Cited by 1,247
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
Doronina, S. O., Toki, B. E., Torgov, M. Y., Mendelsohn, B. A., Cerveny, C. G., Chace, D. F., DeBlanc, R. L., Gearing, R. P., Bovee, T. D., Siegall, C. B., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt832 · Cited by 1,206
Shen, B.-Q., Xu, K., Liu, L., Raab, H., Bhakta, S., Kenrick, M., Parsons-Reponte, K. L., Tien, J., Yu, S.-F., Mai, E., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2108 · Cited by 1,008
Transglutaminases: multifunctional cross‐linking enzymes that stabilize tissues
Greenberg, C. S., Birckbichler, P. J., & Rice, R. H. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.15.1683845 · Cited by 985
Senter, P. D., & Sievers, E. L. (2012) · Nature Biotechnology · doi:10.1038/nbt.2289 · Cited by 763
An Enhanced System for Unnatural Amino Acid Mutagenesis in E. coli
Young, T. S., Ahmad, I., Yin, J. A., & Schultz, P. G. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.10.030 · Cited by 637
Synthesis of site-specific antibody-drug conjugates using unnatural amino acids
Axup, J. Y., Bajjuri, K. M., Ritland, M., Hutchins, B. M., Kim, C. H., Kazane, S. A., Halder, R., Forsyth, J. S., Santidrian, A. F., Stafin, K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211023109 · Cited by 596
Cure of Xenografted Human Carcinomas by BR96-Doxorubicin Immunoconjugates
Trail, P. A., Willner, D., Lasch, S. J., Henderson, A. J., Hofstead, S., Casazza, A. M., Firestone, R. A., Hellström, I., & Hellström, K. E. (1993) · Science · doi:10.1126/science.8327892 · Cited by 556
Glycosylation of Recombinant Antibody Therapeutics
Jefferis, R. (2008) · Biotechnology Progress · doi:10.1021/bp040016j · Cited by 526
Strop, P., Liu, S.-H., Dorywalska, M., Delaria, K., Dushin, R. G., Tran, T.-T., Ho, W.-H., Farias, S., Casas, M. G., Abdiche, Y., et al. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.01.010 · Cited by 505
Lyon, R. P., Setter, J. R., Bovee, T. D., Doronina, S. O., Hunter, J. H., Anderson, M. E., Balasubramanian, C. L., Duniho, S. M., Leiske, C. I., Li, F., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2968 · Cited by 461
LoRusso, P. M., Weiss, D., Guardino, E., Girish, S., & Sliwkowski, M. X. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0762 · Cited by 444
Reduction−Alkylation Strategies for the Modification of Specific Monoclonal Antibody Disulfides
Sun, M. M. C., Beam, K. S., Cerveny, C. G., Hamblett, K. J., Blackmore, R. S., Torgov, M. Y., Handley, F. G. M., Ihle, N. C., Senter, P. D., & Alley, S. C. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050201y · Cited by 370
Zimmerman, E. S., Heibeck, T. H., Gill, A., Li, X., Murray, C. J., Madlansacay, M. R., Tran, C., Uter, N. T., Yin, G., Rivers, P. J., et al. (2014) · Bioconjugate Chemistry · doi:10.1021/bc400490z · Cited by 363
Site‐Specific and Stoichiometric Modification of Antibodies by Bacterial Transglutaminase
Jeger, S., Zimmermann, K., Blanc, A., Grünberg, J., Honer, M., Hunziker, P., Struthers, H., & Schibli, R. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201004243 · Cited by 344
A general approach to site-specific antibody drug conjugates
Tian, F., Lu, Y., Manibusan, A., Sellers, A., Tran, H., Sun, Y., Phuong, T., Barnett, R., Hehli, B., Song, F., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321237111 · Cited by 319
Maturing antibody–drug conjugate pipeline hits 30
Mullard, A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4009 · Cited by 295
Bridging Disulfides for Stable and Defined Antibody Drug Conjugates
Badescu, G., Bryant, P., Bird, M., Henseleit, K., Swierkosz, J., Parekh, V., Tommasi, R., Pawlisz, E., Jurlewicz, K., Farys, M., et al. (2014) · Bioconjugate Chemistry · doi:10.1021/bc500148x · Cited by 290
Occupation and cancer of the lower urinary tract
Cole, P. T., Hoover, R. N., & Friedell, G. H. (1972) · Cancer · doi:10.1002/1097-0142(197205)29:5<1398::aid-cncr2820290542>3.0.co;2-d · Cited by 274
Crystal Structure of Microbial Transglutaminase fromStreptoverticillium mobaraense
Kashiwagi, T., Yokoyama, K.-I., Ishikawa, K., Ono, K., Ejima, D., Matsui, H., & Suzuki, E.-I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203933200 · Cited by 264
Impact of methionine oxidation in human IgG1 Fc on serum half-life of monoclonal antibodies
Wang, W., Vlasak, J., Li, Y., Pristatsky, P., Fang, Y., Pittman, T., Roman, J., Wang, Y., Prueksaritanont, T., & Ionescu, R. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2010.12.009 · Cited by 257
A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy
Maruani, A., Smith, M. E. B., Miranda, E., Chester, K. A., Chudasama, V., & Caddick, S. (2015) · Nature Communications · doi:10.1038/ncomms7645 · Cited by 256
Self-citationSite-specific chemical protein conjugation using genetically encoded aldehyde tags
Rabuka, D., Rush, J. S., deHart, G. W., Wu, P., & Bertozzi, C. R. (2012) · Nature Protocols · doi:10.1038/nprot.2012.045 · Cited by 246
Wu, P., Shui, W., Carlson, B. L., Hu, N., Rabuka, D., Lee, J., & Bertozzi, C. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807820106 · Cited by 237
Hinman, L. M., Hamann, P. R., Wallace, R., Menendez, A. T., Durr, F. E., & Upeslacis, J. (1993) · PubMed · Cited by 236
Site-Specific Antibody–Drug Conjugation through Glycoengineering
Zhou, Q., Stefano, J. E., Manning, C., Kyazike, J., Chen, B., Gianolio, D. A., Park, A., Busch, M., Bird, J., Zheng, X., et al. (2014) · Bioconjugate Chemistry · doi:10.1021/bc400505q · Cited by 223
Drake, P. M., Albers, A. E., Baker, J., Banas, S., Barfield, R. M., Bhat, A. S., de Hart, G. W., Garofalo, A. W., Holder, P., Jones, L. C., et al. (2014) · Bioconjugate Chemistry · doi:10.1021/bc500189z · Cited by 212
Primary structure of microbial transglutaminase from Streptoverticillium sp. strain s-8112
Kanaji, T., Ozaki, H., Takao, T., Kawajiri, H., Ide, H., Motoki, M., & Shimonishi, Y. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50238-1 · Cited by 198
Suppression of tumour growth in mice by a drug–antibody conjugate using a novel approach to linkage
ROWLAND, G. F., O'NEILL, G. J., & DAVIES, D. A. L. (1975) · Nature · doi:10.1038/255487a0 · Cited by 166
Rapid identification of reactive cysteine residues for site-specific labeling of antibody-Fabs
Junutula, J. R., Bhakta, S., Raab, H., Ervin, K. E., Eigenbrot, C., Vandlen, R., Scheller, R. H., & Lowman, H. B. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.12.011 · Cited by 165
Ehrlich, P. F. (1913) · BMJ · doi:10.1136/bmj.2.2746.353 · Cited by 161
Li, X., Fang, T., & Boons, G. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201402606 · Cited by 159
Investigation into Temperature-Induced Aggregation of an Antibody Drug Conjugate
Adeniji, N., Lazzareschi, K. P., Chih, H., Sharma, V. K., & Flores, H. (2013) · Bioconjugate Chemistry · doi:10.1021/bc400182x · Cited by 125
Nunes, J. P. M., Morais, M., Vassileva, V., Robinson, E., Rajkumar, V. S., Smith, M. E. B., Pedley, R. B., Caddick, S., Baker, J. R., & Chudasama, V. (2015) · Chemical Communications · doi:10.1039/c5cc03557k · Cited by 121
Self-citationLocalisation and toxicity study of a vindesine-anti-CEA conjugate in patients with advanced cancer
Ford, C. H. J., Newman, C. E., Johnson, J. R., et al. (1983) · British Journal of Cancer · doi:10.1038/bjc.1983.4 · Cited by 118
Wootton, S. K., & Yoo, D. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.4546-4557.2003 · Cited by 102
Site specific protein labeling by enzymatic posttranslational modification
Sünbül, M., & Yin, J. (2009) · Organic & Biomolecular Chemistry · doi:10.1039/b908687k · Cited by 95
Next-generation disulfide stapling: reduction and functional re-bridging all in one
Lee, M. T. W., Maruani, A., Baker, J. R., Caddick, S., & Chudasama, V. (2015) · Chemical Science · doi:10.1039/c5sc02666k · Cited by 88
Self-citationHamann, P. R., Hinman, L. M., Beyer, C. F., Greenberger, L. M., Lin, C. J., Lindh, D., Menendez, A. T., Wallace, R., Durr, F. E., & Upeslacis, J. (2005) · Bioconjugate Chemistry · doi:10.1021/bc049795f · Cited by 81
Sapra, P., Damelin, M. I., DiJoseph, J. F., Marquette, K., Geles, K. G., Golas, J., Dougher, M. M., Narayanan, B., Giannakou, A., Khandke, K. M., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0603 · Cited by 81
Woo, H. J., Lotz, M. M., Jung, J. U., et al. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55075-4 · Cited by 69
Stan, A. C., Radu, D. L., Casares, S. A., Bona, C. A., & Brumeanu, T. (1999) · PubMed · Cited by 55
Maruani, A., Savoie, H., Bryden, F., Caddick, S., Boyle, R. W., & Chudasama, V. (2015) · Chemical Communications · doi:10.1039/c5cc06985h · Cited by 55
Self-citation
Cited by
Antibody-drug conjugates: recent advances in conjugation and linker chemistries
Tsuchikama, K., & An, Z. (2018) · Protein & Cell · doi:10.1007/s13238-016-0323-0 · Cited by 786
Srinivasarao, M., & Low, P. S. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00013 · Cited by 605
Advances in targeting the folate receptor in the treatment/imaging of cancers
Fernández, M., Javaid, F., & Chudasama, V. (2018) · Chemical Science · doi:10.1039/c7sc04004k · Cited by 539
Self-citationContemporary approaches to site-selective protein modification
Hoyt, E. A., Cal, P. M. S. D., Oliveira, B. L., & Bernardes, G. J. L. (2019) · Nature Reviews Chemistry · doi:10.1038/s41570-019-0079-1 · Cited by 537
Antibody–Drug Conjugates for Cancer Therapy
Hafeez, U., Parakh, S., Gan, H. K., & Scott, A. M. (2020) · Molecules · doi:10.3390/molecules25204764 · Cited by 395
Metadata
- Authors
- Chudasama, V., Maruani, A., & Caddick, S.
- Venue
- Nature Chemistry
- Published
- 2016-01-04
- Volume
- 8
- Issue
- 2
- Pages
- 114-119
- ISSN
- 1755-4330 (ISSN-L)
- 1755-4349
- OpenAlex
- W2272264121
- Cited by
- 352
- References
- 46
- FWCI
- 43.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.